Home
About
Overview
Sharing Data
ORCID
Help
History (64)
Acute exercise remodels promoter methylation in human skeletal muscle.
Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice.
Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes.
Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate.
PPARgamma as a therapeutic target in central nervous system diseases.
See All 64 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PPARgamma as a therapeutic target in central nervous system diseases.
Sundararajan S, Jiang Q, Heneka M, Landreth G. PPARgamma as a therapeutic target in central nervous system diseases. Neurochem Int. 2006 Jul; 49(2):136-44.
View in:
PubMed
subject areas
Animals
Anti-Inflammatory Agents
Brain
Brain Diseases
Disease Models, Animal
Encephalitis
Gene Expression Regulation
Humans
Inflammation Mediators
Neuroprotective Agents
PPAR gamma
Transcriptional Activation
authors with profiles
Michael Thomas Heneka MD